| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $668K | +15.3% | +163.5% |
| Cost of Revenue | $423K | -28.5% | +117.9% |
| Gross Profit | $245K | +2033.2% | +312.6% |
| R&D Expense | $130K | -51.5% | -1.1% |
| SG&A Expense | $1.3M | -2.6% | +13.8% |
| Income Tax | $0 | — | — |
| Net Income | -$1.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.7M | -12.2% | +47.4% |
| Accounts Receivable | $83K | +43.8% | +3.1% |
| Inventory | $1.6M | -2.6% | +78.4% |
| Current Assets | $10.6M | -6.5% | -3.6% |
| Total Assets | $11.2M | -6.4% | -3.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.9M | — | — |
| Capital Expenditures | $55K | — | — |
| Investing Cash Flow | $3.7M | — | — |
| Financing Cash Flow | $6.3M | — | — |
| Free Cash Flow | -$6.0M | — | — |
| -6.7% |
| EPS (Basic) | -$0.38 | +42.4% | +61.6% |
| EPS (Diluted) | -$0.38 | +42.4% | +61.6% |
| $885K |
| +46.0% |
| +35.5% |
| Total Liabilities | $925K | +40.5% | +38.9% |
| Stockholders' Equity | $10.3M | -9.1% | -6.2% |